Innovotech (CVE:IOT) Sets New 1-Year Low – Should You Sell?

Innovotech Inc. (CVE:IOT) hit a new 52-week low on Monday . The company traded as low as C$0.10 and last traded at C$0.09, with a volume of 10000 shares changing hands. The stock had previously closed at C$0.10.

Innovotech Stock Down 10.0%

The company has a quick ratio of 5.81, a current ratio of 2.63 and a debt-to-equity ratio of 12.55. The company’s fifty day moving average price is C$0.14 and its 200-day moving average price is C$0.20. The stock has a market capitalization of C$4.90 million, a PE ratio of -13.22 and a beta of 2.62.

Innovotech Company Profile

Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.